Silexion Reports $3.6 Million Second-Quarter Net Loss as SIL204 Trial Starts

Silexion Therapeutics (NASDAQ: SLXN) reported a net loss of $3.551 million, or $5.17 per basic and diluted share, for the three months ended June 30, 2026. The company reported cash and cash equivalents of $2.229 million at quarter-end.

Silexion said its SIL204 Phase 2/3 trial in locally advanced pancreatic cancer was initiated at Tel Aviv Sourasky Medical Center on July 29, following clinical trial authorizations in Israel and Germany.

• Second-quarter R&D expense was $2.212 million, compared with $1.018 million a year earlier.
• Second-quarter G&A expense was $1.468 million, compared with $1.266 million a year earlier.
• Six-month net loss was $6.284 million, compared with $4.238 million in the prior-year period.
• On August 13, the company closed a public offering with approximately $2.5 million in gross proceeds and approximately $2.1 million in net proceeds.

$SLXNW Hedge Fund Activity

We have seen 1 institutional investors add shares of $SLXNW stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HRT FINANCIAL LP removed 21,260 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $431
• BLUE OWL CAPITAL HOLDINGS LP removed 12,500 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $253
• GOLDMAN SACHS GROUP INC added 2,257 shares (+1.9%) to their portfolio in Q1 2026, for an estimated $45
• CLEAR STREET GROUP INC. removed 600 shares (-0.3%) from their portfolio in Q2 2026, for an estimated $18
• BANK OF AMERICA CORP /DE/ removed 100 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2
• TENOR CAPITAL MANAGEMENT CO., L.P. added 0 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0
• MINT TOWER CAPITAL MANAGEMENT B.V. added 0 shares (+0.0%) to their portfolio in Q1 2026, for an estimated $0

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.